| 000 | 01768nam a2200445 i 4500 | ||
|---|---|---|---|
| 001 | EBC4743126 | ||
| 003 | MiAaPQ | ||
| 005 | 20240121103256.0 | ||
| 006 | m o d | | ||
| 007 | cr cnu|||||||| | ||
| 008 | 161125t20172017sz a ob 000 0 eng d | ||
| 020 | _z9783319432946 | ||
| 020 | _a9783319432960 (e-book) | ||
| 035 | _a(MiAaPQ)EBC4743126 | ||
| 035 | _a(Au-PeEL)EBL4743126 | ||
| 035 | _a(CaPaEBR)ebr11298452 | ||
| 035 | _a(CaONFJC)MIL971626 | ||
| 035 | _a(OCoLC)963696106 | ||
| 040 |
_aMiAaPQ _beng _erda _epn _cMiAaPQ _dMiAaPQ |
||
| 050 | 4 |
_aRC662.18 _b.F574 2017 |
|
| 082 | 0 |
_a616.46206 _223 |
|
| 100 | 1 |
_aFisher, Miles, _eauthor. |
|
| 245 | 1 | 0 |
_aEssentials of SGLT2 inhibitors in diabetes / _cMiles Fisher, Gerard McKay. |
| 264 | 1 |
_a[Cham, Switzerland] : _bAdis, _c2017. |
|
| 264 | 4 | _c2017 | |
| 300 |
_a1 online resource (77 pages) : _bcolor illustrations |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_acomputer _2rdamedia |
||
| 338 |
_aonline resource _2rdacarrier |
||
| 504 | _aIncludes bibliographical references at the end of each chapters. | ||
| 588 | _aDescription based on print version record. | ||
| 590 | _aElectronic reproduction. Ann Arbor, MI : ProQuest, 2016. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. | ||
| 650 | 0 |
_aNon-insulin-dependent diabetes _xTreatment. |
|
| 650 | 0 |
_aDiabetes _xTreatment. |
|
| 655 | 4 | _aElectronic books. | |
| 700 | 1 |
_aMcKay, Gerard, _eauthor. |
|
| 776 | 0 | 8 |
_iPrint version: _aFisher, Miles. _tEssentials of SGLT2 inhibitors in diabetes. _d[Cham, Switzerland] : Adis, c2017 _hxi, 68 pages _z9783319432946 _w2016955416 |
| 797 | 2 | _aProQuest (Firm) | |
| 856 | 4 | 0 |
_uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=4743126 _zClick to View |
| 999 |
_c275771 _d275771 |
||